OTC · Health care

Revium Rx. (RVRC)

It posted a net loss of $13.4M. At June 30, 2026 it held $842K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Watch RVRC in 60 seconds

Price

$1.43

0.00% on the day · September 25, 2026

52-week range $0.52 to $1.67

Market cap

$86.8M

What Revium Rx. does

Revium Rx. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker RVRC.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	n/a	n/a	-$13.4M	-$0.22	n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around October 20, 2026.

Estimated from its filing rhythm: about 68 days after its last report of August 13, 2026, its usual gap. Not a date the company has announced. See the report calendar

Latest SEC filings

What Revium Rx. has filed recently, newest first. Each links to the original document on SEC EDGAR.

August 13, 2026
Quarterly report 10-Q · period to June 30, 2026Diluted EPS $0.01 versus $0.02.
June 22, 2026
Executive or director change 8-K
June 1, 2026
Executive or director change 8-K
May 14, 2026
Quarterly report 10-Q · period to March 31, 2026Diluted EPS $0.01 versus $0.01.
April 20, 2026
Executive or director change 8-K
March 31, 2026
Annual report 10-K · period to December 31, 2025Diluted EPS was -$0.22.
January 28, 2026
IPO registration (amended) S-1/A
January 16, 2026
IPO registration (amended) S-1/A
December 12, 2025
IPO registration (amended) S-1/A
October 3, 2025
IPO registration (amended) S-1/A

All filings on SEC EDGAR

Questions about RVRC

What does Revium Rx. do?

Revium Rx. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker RVRC.

Is Revium Rx. profitable?

No. In fiscal 2025 it reported a net loss of $13.4M.

When did Revium Rx. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026.

Similar companies

TAK

Takeda Pharmaceutical Co Ltd

Compare RVRC with

Compare RVRC with any company

Follow RVRC

Get an email when Revium Rx. files with the SEC: results, executive changes, material agreements and annual reports.

Follow RVRC: get an email when it files

Where the numbers come from

Financial figures are the values Revium Rx. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.